2026-10-09T01:24:55Z https://api.figshare.com/v2/oai

oai:figshare.com:article/33195924 2026-10-02T13:13:30Z category_24490 portal_975 item_type_6 month_year_10_2026

Supplementary data for the manuscript: Efficacy of abrocitinib and dupilumab on chronic hand eczema in patients with moderate-to-severe atopic dermatitis: a prespecified exploratory analysis of the phase 3 JADE DARE study Robert Bissonnette (2735341) Vivian Shi (8563863) Ana Giménez-Arnau (6578330) Marie-Noëlle Crépy (23643650) Marie L.A. Schuttelaar (16858703) Irina Lazariciu (6561707) Tamara Bratt (25302395) Andrew Selfridge (281897) Gerardo Encinas (23946326) Herwig Koppensteiner (252909) Dermatology Atopic dermatitis eczema abrocitinib Cibinqo dupilumab Dupixent CHE hand eczema dermatology <p dir="ltr">Supplementary material for “Efficacy of abrocitinib and dupilumab on chronic hand eczema in patients with moderate-to-severe atopic dermatitis: a prespecified exploratory analysis of the phase 3 JADE DARE study” manuscript published in the <i>Journal of the American Academy of Dermatology (JAAD).</i></p> 2026-10-02T13:13:30Z Text Journal contribution 10.25454/pfizer.figshare.33195924.v2 https://figshare.com/articles/journal_contribution/Supplementary_data_for_the_manuscript_Efficacy_of_abrocitinib_and_dupilumab_on_chronic_hand_eczema_in_patients_with_moderate-to-severe_atopic_dermatitis_a_prespecified_exploratory_analysis_of_the_phase_3_JADE_DARE_study/33195924 CC BY-NC-ND 4.0